Cargando…

STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells

Background: Oncolytic viruses (OVs) are emerging as potent inducers of immunogenic cell death (ICD), releasing danger-associated molecular patterns (DAMPs) that induce potent anticancer immunity. Oncolytic Newcastle disease virus (NDV) has been shown to educe ICD in both glioma and lung cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Xiaoyan, Wang, Xueke, Guo, Xianling, Jiang, Ke, Ye, Tian, Chen, Jianhua, Fang, Juemin, Gu, Linaer, Wang, Sitong, Zhang, Guirong, Meng, Songshu, Xu, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548873/ https://www.ncbi.nlm.nih.gov/pubmed/31192135 http://dx.doi.org/10.3389/fonc.2019.00436

Ejemplares similares

Targeting STAT3 enhances NDV‐induced immunogenic cell death in prostate cancer cells
por: Wang, Xueke, et al.
Publicado: (2020)

Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
por: Jiang, Ke, et al.
Publicado: (2018)

Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
por: Bommareddy, Praveen K., et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

The oncolytic peptide LTX-315 triggers immunogenic cell death
por: Zhou, H, et al.
Publicado: (2016)

Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
por: Jiang, Ke, et al.
Publicado: (2014)

Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma
por: Numpadit, Supaporn, et al.
Publicado: (2023)

Targeting STAT3 Abrogates Tim-3 Upregulation of Adaptive Resistance to PD-1 Blockade on Regulatory T Cells of Melanoma
por: Huang, Lili, et al.
Publicado: (2021)

Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma
por: Vijayakumar, Gayathri, et al.
Publicado: (2019)

Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment
por: Wang, Jiandong, et al.
Publicado: (2023)

Adaptation of the Newcastle Disease Virus to Cell Cultures for Enhancing Its Oncolytic Properties
por: Yurchenko, K. S., et al.
Publicado: (2019)

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes
por: Heinrich, B, et al.
Publicado: (2017)

Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
por: Meng, Gang, et al.
Publicado: (2014)

Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Targeting Autophagy for Oncolytic Immunotherapy
por: Hu, Lulu, et al.
Publicado: (2017)

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
por: Huang, Fang, et al.
Publicado: (2022)

The Oncolytic Virus dl922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
por: Di Somma, Sarah, et al.
Publicado: (2019)

Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
por: Ma, Jing, et al.
Publicado: (2020)

Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
por: Wu, Yi-Ying, et al.
Publicado: (2023)

Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth
por: Furukawa, Natsuki, et al.
Publicado: (2023)

Measles virus causes immunogenic cell death in human melanoma
por: Donnelly, Oliver G, et al.
Publicado: (2011)

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
por: Fournier, Philippe, et al.
Publicado: (2013)

Therapeutic potential of oncolytic Newcastle disease virus: a critical review
por: Tayeb, Shay, et al.
Publicado: (2015)

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
por: Pathak, Upasana, et al.
Publicado: (2023)

Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
por: Obaid, Qayssar A., et al.
Publicado: (2022)

Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model
por: Yamano, Tomoki, et al.
Publicado: (2016)

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
por: Liu, Tianyan, et al.
Publicado: (2020)

From threat to cure: understanding of virus-induced cell death leads to highly immunogenic oncolytic influenza viruses
por: Kabiljo, Julijan, et al.
Publicado: (2020)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
por: Schirrmacher, Volker, et al.
Publicado: (2022)

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells
por: Davola, Maria Eugenia, et al.
Publicado: (2023)

Oncolytic viruses in melanoma
por: Robinson, Camille, et al.
Publicado: (2022)

Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy
por: Li, Xiaoyan, et al.
Publicado: (2023)

Newcastle disease virus-vectored West Nile fever vaccine is immunogenic in mammals and poultry
por: Wang, Jinliang, et al.
Publicado: (2016)

The oncolytic peptide LTX-315 induces cell death and DAMP release by mitochondria distortion in human melanoma cells
por: Eike, Liv-Marie, et al.
Publicado: (2015)

Newcastle-disease-virus-induced ferroptosis through nutrient deprivation and ferritinophagy in tumor cells
por: Kan, Xianjin, et al.
Publicado: (2021)

Multimodal Cancer Therapy Involving Oncolytic Newcastle Disease Virus, Autologous Immune Cells, and Bi-Specific Antibodies
por: Schirrmacher, Volker, et al.
Publicado: (2014)

Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
por: Meng, Chunchun, et al.
Publicado: (2012)

Oncolytic Herpes Simplex Virus Type 1 Induces Immunogenic Cell Death Resulting in Maturation of BDCA-1(+) Myeloid Dendritic Cells
por: Kalus, Philipp, et al.
Publicado: (2022)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
por: Buijs, Pascal, et al.
Publicado: (2015)

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
por: Schirrmacher, Volker, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cnof27tnp2m87lf0e6l24gjvct